Nancy H.

Bellingham, WA

Nancy Shares Testimonial for COPD Treatment at the Lung Institute

Age: 72  |  Location: Bellingham, WA  |  Condition: COPD

Nancy H. was diagnosed with COPD in 2006. The disease hit her hard last winter. She used to walk 6,000 steps a day, but had difficulty even making 500 steps. Her traditional treatments were no longer working. Her husband, a physician, contacted the Lung Institute and after a few conversations they had her first cellular therapy treatment set up. Right after that treatment she felt she had more energy.

When she got back to her home in Washington she walked up a flight of steps where she had previously had to pull herself up or stop every couple steps to catch her breath. Nancy gives the Lung Institute full credit for her improved health. “They’re bringing me back,” she said.

If you or someone you love has COPD, emphysema, pulmonary fibrosis or another chronic lung disease and would like to learn more about cellular therapy, contact us at (800) 729-3065.

Are you a candidate? Call (800) 729-3065 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.